These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

124 related articles for article (PubMed ID: 26721527)

  • 1. CMS sends pharmacists some good news for Medicare Part B.
    Thompson CA
    Am J Health Syst Pharm; 2016 Jan; 73(2):12-4. PubMed ID: 26721527
    [No Abstract]   [Full Text] [Related]  

  • 2. CMS changes for 2009.
    W V Med J; 2009; 105(1):38. PubMed ID: 19146045
    [No Abstract]   [Full Text] [Related]  

  • 3. CMS drops employment requirement for 'incident-to' billing by pharmacists.
    Am J Health Syst Pharm; 2002 Feb; 59(3):225. PubMed ID: 11862628
    [No Abstract]   [Full Text] [Related]  

  • 4. CMS announced new 2009 HCPCS codes for skin substitutes.
    Schaum KD
    Adv Skin Wound Care; 2009 Jan; 22(1):18-9. PubMed ID: 19096279
    [No Abstract]   [Full Text] [Related]  

  • 5. CMS chief affirms incident-to billing for pharmacists is allowed.
    Traynor K
    Am J Health Syst Pharm; 2014 Jun; 71(12):977-8. PubMed ID: 24865750
    [No Abstract]   [Full Text] [Related]  

  • 6. Observation care stirs ire. JAMA study says CMS policy hurts hospitals' bottom lines.
    Carlson J
    Mod Healthc; 2013 Jul; 43(28):8-9. PubMed ID: 24044229
    [No Abstract]   [Full Text] [Related]  

  • 7. Competitive bidding: an update.
    Comeaux L; Davis J; Lavanty D
    Clin Lab Sci; 2007; 20(2):66-8. PubMed ID: 17557703
    [No Abstract]   [Full Text] [Related]  

  • 8. HCFA clarifies 'incident-to' billing by pharmacists.
    Am J Health Syst Pharm; 2000 Sep; 57(17):1557-8. PubMed ID: 10984801
    [No Abstract]   [Full Text] [Related]  

  • 9. Medical groups can receive 2% bonus from CMS.
    Manag Care; 2010 Feb; 19(2):11. PubMed ID: 20550046
    [No Abstract]   [Full Text] [Related]  

  • 10. Don't exclude community pharmacists.
    Hoey BD
    Mod Healthc; 2014 Mar; 44(10):26. PubMed ID: 24830277
    [No Abstract]   [Full Text] [Related]  

  • 11. 2007 update: RBRVS physician fee schedule for wound management procedures.
    Schaum KD
    Adv Skin Wound Care; 2007 Apr; 20(4):192, 194, 196. PubMed ID: 17415026
    [No Abstract]   [Full Text] [Related]  

  • 12. Uptake and cost of biosimilar filgrastim among Medicare and Medicaid populations in 2015-2018.
    Qian J
    J Manag Care Spec Pharm; 2021 May; 27(5):660-666. PubMed ID: 33908273
    [No Abstract]   [Full Text] [Related]  

  • 13. Introduction. Update on pharmaceutical reimbursement and implications for health-system pharmacists .
    Johnson PE
    Am J Health Syst Pharm; 2008 Jan; 65(2 Suppl 1):S2-3. PubMed ID: 18192244
    [No Abstract]   [Full Text] [Related]  

  • 14. Docs, seniors get more bad news. Medicare premiums to rise even more than expected.
    Loos R
    Mod Healthc; 2005 Apr; 35(14):12-3. PubMed ID: 15825949
    [No Abstract]   [Full Text] [Related]  

  • 15. Medicare program; Medicare Hospital Insurance (Part A) and Medicare Supplementary Medical Insurance (Part B). Notice of CMS ruling.
    Centers for Medicare & Medicaid Services (CMS), HHS
    Fed Regist; 2013 Mar; 78(52):16614-7. PubMed ID: 23530288
    [TBL] [Abstract][Full Text] [Related]  

  • 16. CMS is on the case as physician spending, part B premiums rise.
    Med Health; 2005 Apr; 59(12):1-3. PubMed ID: 15847283
    [No Abstract]   [Full Text] [Related]  

  • 17. Part A to part B rebilling: understanding the rules in a changing environment.
    Polston M
    Healthc Financ Manage; 2013 Jun; 67(6):64-6. PubMed ID: 23795379
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Paying accurately for imaging services in medicare.
    Winter A; Ray N
    Health Aff (Millwood); 2008; 27(6):1479-90. PubMed ID: 18997203
    [TBL] [Abstract][Full Text] [Related]  

  • 19. CMS proposal on Part B drugs deserves support.
    Goozner M
    Mod Healthc; 2016 Jul; 46(26-27):34. PubMed ID: 30480898
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Unintended Consequences in Cancer Care Delivery Created by the Medicare Part B Proposal: Is the Clinical Rationale for the Experiment Flawed?
    Gordan L; Grogg A; Blazer M; Fortner B
    J Oncol Pract; 2017 Feb; 13(2):e139-e151. PubMed ID: 28029298
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 7.